A Canadian MDMA production milestone has drawn attention to the next stage of psychedelic research. Here is what Phase 3 trials mean, how MDMA differs from psilocybin, and why approval is still not guaranteed.
Mushroom edibles can be difficult to evaluate because labels, ingredients, potency, and onset times vary. This Canadian safety guide explains unexpected effects, warning signs, and practical harm-reduction steps.
A reported Okanagan prosecution has renewed questions about psilocybin trafficking charges in Canada. Here is what buyers and sellers should understand about possession, distribution, enforcement, and legal risk.
Amanita muscaria and psilocybin mushrooms are often grouped together as mushroom products, but they are chemically and legally different. This Canadian guide explains the main differences, expected effects, product-label questions, and important safety considerations.
Interest in psychedelic therapy in Canada is expanding beyond veterans. Learn who is seeking support, what current evidence says, how legal access works, and why screening and professional care matter.
Magic mushroom gummies can be confusing, especially when product labels use terms such as mushroom blend, psychedelic, microdose, or proprietary formula. This Canadian-focused guide explains what to check before consuming any mushroom edible, why labels may be unreliable, how gummies differ from dried mushrooms, and what beginners should understand about safety and Canadian law.
A recent Canadian case involving alleged psilocybin-only sales has renewed questions about enforcement, online orders, possession, and personal risk. Here is what Canadians should understand before making decisions about magic mushrooms.
Psilocybin research in Canada is expanding, but clinical trials are very different from casual mushroom use. Learn how studies work, what researchers measure, and how Canadians can interpret psychedelic claims responsibly.
Health Canada headlines and psilocybin industry news can be confusing for everyday Canadians. This guide explains what the latest developments actually mean for users, patients, and anyone curious about magic mushrooms in Canada.
Canada’s psilocybin rules are stricter than many people assume, but there are real legal pathways for patients and researchers. This guide breaks down Section 56 exemptions, Health Canada’s Special Access Program, clinical trial access, and the practical limits every Canadian should understand before pursuing psilocybin legally.
By proceeding you affirm the statements above are true. This site uses cookies to remember your verification status. Privacy Policy.